AP poll: Only half of Americans say they would get COVID-19 vaccine

If the unprecedented global race for the first effective human coronavirus vaccine is successful, only 49 percent of Americans say they would get the vaccine, according to an Associated Press-NORC Center for Public Affairs Research poll released Wednesday morning. Another 31 percent said they were not sure while 20 percent said they would not get the vaccine. About 70 percent of those currently refusing the future vaccine cited safety concerns, while an equal share of those who would get a vaccine said it's the only way to get life back to normal. The top reason among people who said yes was to protect their family and community.
"There's still a large amount of uncertainty around taking the vaccine," NORC's Caitlin Oppenheimer told AP. "There is a lot of opportunity to communicate with Americans about the value and the safety of a vaccine." Dr. Francis Collins, director of the National Institutes of Health, gave it a shot. "I would not want people to think that we're cutting corners because that would be a big mistake," he told the AP earlier this month. "Definitely the worst thing that could happen is if we rush through a vaccine that turns out to have significant side effects." The NIH is drawing up plans to test successful COVID-19 vaccine candidates in tens of thousands of people to make sure they are effective and safe.
Older Americans, whites, and Democrats were more likely to say yes to the vaccine, while respondents under 60, Republicans, and black and Hispanic Americans were more likely to pass. The AP-NORC poll was conducted May 14-18 among 1,056 adults. It has a margin of sampling error of ±4.2 percentage points.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Peter has worked as a news and culture writer and editor at The Week since the site's launch in 2008. He covers politics, world affairs, religion and cultural currents. His journalism career began as a copy editor at a financial newswire and has included editorial positions at The New York Times Magazine, Facts on File, and Oregon State University.
-
Ukrainian election: who could replace Zelenskyy?
The Explainer Donald Trump's 'dictator' jibe raises pressure on Ukraine to the polls while the country is under martial law
By Sorcha Bradley, The Week UK Published
-
The battle for 21st century naturism laid bare
In The Spotlight Nudist lifestyle falling out of favour in Germany but naked attraction is on the rise in the UK
By Chas Newkey-Burden, The Week UK Published
-
The Week Unwrapped: Why do young people love ASMR?
Podcast Plus can US football stamp out homophobia? And why is Scottish Gallic getting a TV boost?
By The Week UK Published
-
Texas outbreak brings 1st US measles death since 2015
Speed read The outbreak is concentrated in a 'close-knit, undervaccinated' Mennonite community in rural Gaines County
By Rafi Schwartz, The Week US Published
-
Mystery illness spreading in Congo rapidly kills dozens
Speed Read The World Health Organization said 53 people have died in an outbreak that originated in a village where three children ate a bat carcass
By Peter Weber, The Week US Published
-
Ozempic can curb alcohol cravings, study finds
Speed read Weight loss drugs like Ozempic and Wegovy may also be helpful in limiting alcohol consumption
By Peter Weber, The Week US Published
-
New form of H5N1 bird flu found in US dairy cows
Speed Read This new form of bird flu is different from the version that spread through herds in the last year
By Peter Weber, The Week US Published
-
Microplastics accumulating in human brains, study finds
Speed Read The amount of tiny plastic particles found in human brains increased dramatically from 2016 to 2024
By Peter Weber, The Week US Published
-
FDA approves painkiller said to thwart addiction
Speed Read Suzetrigine, being sold as Journavx, is the first new pharmaceutical pain treatment approved by the FDA in 20 years
By Rafi Schwartz, The Week US Published
-
Study finds possible alternative abortion pill
Speed Read An emergency contraception (morning-after) pill called Ella could be an alternative to mifepristone for abortions
By Peter Weber, The Week US Published
-
California declares bird flu emergency
Speed Read The emergency came hours after the nation's first person with severe bird flu infection was hospitalized
By Rafi Schwartz, The Week US Published